Parkinson’s Disease

Parkinson´s disease is a progressive neurodegenerative disorder.

The unique features of Infudopa™

Our products in development

“I have an ethical responsibility to contribute to Infudopa becoming available to patients suffering from Parkinson’s disease”

– Arvid Carlsson (1923-2018) who received the Nobel prize in 2000 for the discoveries that paved the way for the introduction of levodopa as treatment for Parkinson´s disease.

Report from the General Meeting of Dizlin Pharmaceuticals AB

Dizlin Pharmaceuticals held a General Meeting on May 28, 2020. The ordinary board members Leif Bring, Staffan Schüberg, Elias Eriksson, Anders Stenström and Nil Dizdar were re-elected. Anders Tullgren, Åsa Hansdotter and Johan von Heijne [...]

Read all news
Go to Top